How to Get AndroGel in Maryland

What Is AndroGel and Why Maryland Patients Need a Prescription

AndroGel is a topical testosterone replacement approved by the FDA for adult males with hypogonadism confirmed by clinical symptoms and at least two low morning serum testosterone measurements. The FDA label lists the approved indication as primary or hypogonadotropic hypogonadism; off-label use in women is not covered here. Because testosterone is a Schedule III controlled substance under the Controlled Substances Act, every AndroGel prescription in Maryland must come from a DEA-registered prescriber writing within a valid prescriber-patient relationship. 1

The T-Trials, a coordinated set of seven double-blind placebo-controlled trials in 788 men aged 65 and older with total testosterone below 275 ng/dL, showed that testosterone gel significantly improved sexual function scores, bone density, and anemia compared with placebo at 12 months. 2 Those results inform current clinical guidelines used by Maryland prescribers when deciding who qualifies.

The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy only when there is "unequivocal biochemical evidence of testosterone deficiency," defined as total testosterone below 264 ng/dL on two separate morning samples. 3 Maryland physicians follow that threshold when writing AndroGel prescriptions, and most telehealth platforms apply the same cutoff to stay within standard-of-care boundaries.

Gel formulations transfer testosterone transdermally, bypassing first-pass hepatic metabolism. The 1.62% formulation (AndroGel 1.62%) delivers 20.25 mg, 40.5 mg, 60.75 mg, or 81 mg per actuation-pump dose; the 1% formulation delivers 25 mg or 50 mg per packet. 1 Your prescriber will select the starting dose based on your baseline testosterone level and symptom burden, then titrate at the 4-week and 8-week follow-up labs.

Maryland Telehealth Rules for AndroGel Prescriptions

Maryland explicitly permits telehealth prescribing of Schedule III controlled substances, including testosterone, provided the prescriber holds an active Maryland medical license, a DEA registration listing Maryland as a state of practice, and documents a thorough patient evaluation including a review of uploaded lab results. 4 The prescriber is not required to conduct an in-person physical exam before the telehealth visit when established clinical criteria are met, which means the entire process from consult to prescription can occur remotely.

Maryland's Board of Physicians and Board of Nursing both recognize telehealth encounters as valid for initiating a new controlled-substance prescription when the practitioner can view the patient in real time by two-way audio-visual connection and can independently review lab data. Asynchronous (store-and-forward) encounters alone are not sufficient for a Schedule III prescription in Maryland.

Practical steps for a telehealth AndroGel prescription in Maryland:

1. Order or upload morning serum testosterone labs (see the lab section below).
2. Book a synchronous video visit with a Maryland-licensed MD, DO, NP, or PA who holds DEA registration.
3. The prescriber reviews symptoms, labs, and medical history during the visit.
4. If criteria are met, an e-prescription is sent electronically to your chosen Maryland pharmacy.
5. Because testosterone is Schedule III, some platforms issue a 30-day supply with up to five refills on a single prescription; others send a new prescription each month.

Telehealth platforms operating in Maryland include national TRT-focused services and general men's health practices. Confirm that the specific provider you choose holds a Maryland state license before you book; many national platforms employ providers licensed in only a subset of states. 5

Required Labs Before Getting AndroGel in Maryland

No reputable Maryland prescriber will write an AndroGel prescription without lab confirmation. Two separate morning total testosterone values below 264 ng/dL are required by the Endocrine Society guideline. 3 A single low value can reflect the normal circadian nadir or an acute illness; repeating the draw on a different day eliminates those confounders.

The standard pre-treatment lab panel used by Maryland TRT practices includes:

• Total testosterone (drawn between 7 a.m. and 10 a.m.)
• Free testosterone (calculated or equilibrium dialysis method)
• LH and FSH (to classify primary vs. hypogonadotropic hypogonadism)
• Complete blood count with hematocrit (baseline before gel increases erythropoiesis)
• Prostate-specific antigen (PSA) for men aged 40 and older
• Estradiol (E2) baseline
• Metabolic panel with fasting glucose and lipids
• Prolactin (if LH and FSH are low, to rule out a pituitary adenoma)

The FDA label for AndroGel contraindicates use in men with known or suspected breast or prostate cancer, and recommends that prescribers assess PSA and hematocrit at 3 to 6 months, then annually. 1 Hematocrit above 54% is a threshold for dose reduction or temporary discontinuation per the FDA label.

Quest Diagnostics and LabCorp both have draw sites across Maryland, including Baltimore, Rockville, Silver Spring, Annapolis, and Frederick. Most telehealth platforms provide a lab requisition you can take to any nearby draw site; results typically return within 24 to 48 hours and upload directly to your patient portal. 6

Who Can Prescribe AndroGel in Maryland

Maryland permits four prescriber types to write Schedule III controlled-substance prescriptions, provided each holds an active Maryland license and DEA registration:

Medical Doctors (MD) and Doctors of Osteopathic Medicine (DO). Both have independent prescriptive authority for all controlled substances in Maryland. Urologists, endocrinologists, internists, and family medicine physicians all regularly manage TRT in this state.

Nurse Practitioners (NP). Maryland NPs with prescriptive authority and a Schedule III DEA registration may independently prescribe AndroGel. Maryland enacted full practice authority for NPs in 2021, removing the requirement for a collaborative agreement with a physician. NPs practicing in telehealth TRT platforms are increasingly the first-line prescriber in Maryland. 7

Physician Assistants (PA). PAs in Maryland may prescribe Schedule III substances under a delegation agreement with a supervising physician. The delegation agreement must be on file with the Maryland Board of Physicians. In a telehealth setting, the supervising physician reviews a sample of PA prescriptions but does not need to co-sign each individual prescription.

All four prescriber types may use the Maryland Prescription Drug Monitoring Program (PDMP), known as CRISP (Chesapeake Regional Information System for our Patients), to check a patient's controlled-substance history before prescribing. Maryland law requires prescribers to query CRISP before initiating a new Schedule III prescription. 8

Maryland Pharmacies That Dispense AndroGel

Retail chain pharmacies. CVS, Walgreens, Rite Aid, and Giant Food pharmacies throughout Maryland stock both the 1% and 1.62% AndroGel formulations. Brand-name AndroGel carries a list price of roughly $500 to $600 per month without insurance; generic testosterone gel 1% (manufactured by Perrigo and Actavis, among others) lists at $80 to $160 per month and is therapeutically equivalent. Your prescriber can write "substitution permitted" to allow the pharmacist to dispense the generic.

GoodRx and manufacturer coupons. AbbVie's AndroGel patient assistance program and GoodRx can reduce out-of-pocket cost at Maryland retail pharmacies. GoodRx pricing for generic testosterone gel 1% (50 mg/packet, 30-count) ranges from $45 to $90 at Maryland pharmacies as of early 2025, depending on location and chain. 9

503A compounding pharmacies. Maryland-licensed 503A compounding pharmacies may prepare testosterone gel in custom concentrations (commonly 2%, 5%, or 10%) when a prescriber documents a clinical need not met by the commercial product. The FDA defines 503A pharmacies as those that compound based on individual patient-specific prescriptions from licensed practitioners; they are not permitted to manufacture large batches for general dispensing. 10 Compounded testosterone gel from a Maryland 503A pharmacy requires the same Schedule III prescription as brand AndroGel. Shipping from an in-state 503A to a Maryland patient address is legal; out-of-state 503A pharmacies may ship into Maryland if they hold reciprocal licensure with the Maryland Board of Pharmacy.

Mail-order options. Express Scripts, OptumRx, and CVS Caremark all service Maryland patients and can fill testosterone gel prescriptions with appropriate insurance or cash-pay authorization. Schedule III prescriptions in Maryland may be transmitted electronically (e-prescribe) or by fax; handwritten paper prescriptions are not required but remain valid.

Maryland Medicaid and Insurance Prior Authorization for AndroGel

Maryland Medicaid (HealthChoice) covers brand AndroGel and generic testosterone gel for male hypogonadism diagnoses (ICD-10 E23.0, E29.1) with prior authorization. 11 The prior authorization process typically requires:

1. A documented diagnosis of hypogonadism with ICD-10 code.
2. Two separate morning total testosterone values below the plan's threshold (most Maryland Medicaid MCOs use <300 ng/dL).
3. Documentation that the prescriber is a licensed Maryland provider.
4. A statement that the patient has symptomatic hypogonadism (fatigue, low libido, erectile dysfunction, decreased muscle mass).

Private insurers in Maryland, including CareFirst BlueCross BlueShield, Aetna, UnitedHealthcare, and Kaiser Permanente Mid-Atlantic, generally require the same documentation set plus may require a trial of generic testosterone gel before approving brand AndroGel. Prior authorization approvals typically take 3 to 10 business days once the complete documentation package is submitted. If denied, Maryland law gives patients the right to an expedited appeal within 72 hours for urgent medical needs. 12

Step therapy requirements from Maryland commercial plans often sequence as follows: generic testosterone gel first, then brand AndroGel if the generic is not tolerated or produces inadequate serum levels at maximum dose. Your prescriber can request a step-therapy exception if clinical documentation supports skipping the generic trial.

How Long Until You Receive AndroGel in Maryland

Timeline depends on whether you already have labs and whether insurance PA is needed.

Fastest path (cash-pay, labs already done). Telehealth video visit booked same day or next day. Prescription sent electronically to a Maryland retail pharmacy within minutes of the visit. Same-day pickup is common at most chain pharmacies if the prescription arrives before 3 p.m. Total time: 1 to 2 days from booking to first application.

Moderate path (cash-pay, labs needed first). Lab order sent by telehealth prescriber. Patient completes morning draw at a local Quest or LabCorp site. Results return in 24 to 48 hours. Telehealth visit scheduled after results are available. Prescription sent to pharmacy. Total time: 3 to 5 business days.

Longest path (insurance with PA required). Add 3 to 10 business days for the PA decision after labs and clinical documentation are submitted. If the prescriber's office uses an electronic PA tool (CoverMyMeds is used widely in Maryland), turnaround can shorten to 1 to 3 business days for straightforward cases. Total time: 7 to 14 business days.

Compounded testosterone gel from a Maryland 503A pharmacy may add 2 to 3 business days for compounding and shipping after the prescription is received.

Applying AndroGel Correctly to Maximize Absorption and Prevent Transfer

The FDA label mandates application to clean, dry, intact skin of the shoulders, upper arms, or abdomen (for 1.62%) or shoulders and upper arms only (for 1%). 1 Apply after a shower in the morning. Allow the gel to dry for at least 5 minutes before dressing.

Skin-to-skin transfer to women and children is a serious safety concern. The FDA issued a black-box warning on all testosterone gel products after reports of virilization in children who had secondary contact with treated adults. 1 Maryland prescribers are required to counsel patients on this risk at initiation. Practical transfer-prevention steps include covering the application site with clothing, washing hands immediately, and avoiding skin contact with others for at least 2 hours after application. If contact occurs, the other person should wash the exposed area with soap and water immediately.

Avoid applying AndroGel to the scrotum or bony prominences. Do not use on skin with open sores, rashes, or active dermatitis. Showering or swimming within 6 hours of application reduces absorption; waiting the full 6 hours maintains the expected serum AUC. 13

Monitoring After Starting AndroGel in Maryland

The Endocrine Society guideline recommends checking serum testosterone 3 to 6 months after starting gel therapy, targeting mid-normal range (400 to 700 ng/dL) at trough (just before the next application). 3 Hematocrit should be re-checked at 3 months and 6 months; a value above 54% warrants dose reduction, temporary discontinuation, or phlebotomy. PSA should be repeated at 3 to 6 months in men over 40, then annually. Bone mineral density is assessed at 1 to 2 years in men with osteoporosis or low trauma fractures at baseline. 14

Estradiol monitoring is particularly relevant for gel users because aromatization of exogenous testosterone produces estradiol; men with estradiol above 40 to 50 pg/mL on gel may develop gynecomastia or fluid retention. Some Maryland prescribers co-prescribe anastrozole 0.5 mg twice weekly for symptomatic estradiol elevation, though the Endocrine Society guideline notes that evidence for routine AI use in TRT is limited. 3

The HealthRX Maryland TRT Monitoring Schedule below summarizes the recommended cadence for gel users based on the Endocrine Society 2018 guideline and FDA label requirements:

| Timepoint | Labs Required | |---|---| | Baseline | Total T, free T, LH, FSH, CBC, hematocrit, PSA (men >40), estradiol, metabolic panel, prolactin | | 3 months | Total T (trough), hematocrit, PSA | | 6 months | Total T (trough), hematocrit, PSA, estradiol | | 12 months | Full panel as baseline | | Annually thereafter | Total T, hematocrit, PSA, CBC |

Transferring an Existing AndroGel Prescription to Maryland

If you move to Maryland with an active AndroGel prescription from another state, Maryland pharmacies can fill a valid out-of-state Schedule III prescription from a DEA-registered out-of-state prescriber for up to a 30-day supply. Beyond that initial fill, you need a Maryland-licensed prescriber to continue therapy. 15

The simplest transfer path is a telehealth visit with a Maryland-licensed provider. Bring your previous prescription records, lab history, and any prior authorization approval letters from your prior insurer. Most Maryland TRT practices accept out-of-state labs drawn within the previous 6 months, avoiding the need to repeat the full baseline panel immediately. If your previous testosterone values were borderline (300 to 400 ng/dL), expect the new Maryland provider to request a fresh morning draw before continuing the prescription.

For insurance continuity, contact your Maryland insurer's pharmacy benefit manager before your move to confirm whether your existing PA approval transfers or whether a new PA is required under the Maryland plan. CareFirst and Kaiser Mid-Atlantic both require new PA submissions for members establishing Maryland residency, even with prior approval from another state plan. 16